To confirm the link between epigenetic modifications and NMT2 expression, rapidly growing lymphoma cells were treated with high concentrations of deoxyazacytidine (DAC) to inhibit DNA methylation and/or suberoylanilide hydroxamic acid (SAHA) to inhibit histone deacetylation [30] for 24 h (Fig. 2D–G). The gene discussed is NMT2; the disease is lymphoma.